PROPEL Contour receives CE mark. Click here to learn more. Fiagon AG Medical Technologies is now part of Intersect ENT – Click here to learn more about our navigation offering. Products Company Investors News Careers DELIVERING INNOVATION. WHERE IT’S NEEDED. Intersect ENT is a medical technology company dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation. We provide treatments for people with chronic sinusitis, an inflammatory sinus condition that has been shown to substantially reduce quality of life. Sinusitis is one of the most common conditions in the United States. PRODUCTS WITH THE POWER TO CHANGE LIVES The simple choice for patients with chronic sinusitis undergoing balloon sinus dilation. LEARN MORE LOCALIZED STEROID-RELEASING TECHNOLOGY Our core technology is our bioabsorbable drug release platform. The current portfolio of sinus implants is designed to provide mechanical support and localized drug delivery. OUR PRODUCTS DRIVEN BY PURPOSE Intersect ENT was founded to find a better way to improve both the patientexperience and surgical outcomes of people with chronic sinusitis. OUR COMPANY JOINED BY CULTURE From scientists to marketers, we are looking for talented team members that can thrive in a dynamic environment with lots of autonomy. Are you ready to join the team? CAREERS STAY INFORMED ABOUT INTERSECT ENT Contact Us | Privacy Policy | Terms and Conditions | 1555 Adams Drive | Menlo Park, CA 94025 | 650.641.2100 ©2021 Intersect ENT, Inc. All rights reserved. MPM-10679 Rev 16.0 INTERSECT ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries.